FDA Inspection 1263981 — Penn State Health Hampden Medical Center
The FDA completed an inspection of Penn State Health Hampden Medical Center on March 12, 2025 in Enola, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Enola, PA (United States)